PK Vs Analytical [Bioanalytics]

posted by Helmut Homepage – Vienna, Austria, 2007-07-23 20:04 (6496 d 15:23 ago) – Posting: # 926
Views: 12,472

Dear Charl!

❝ what is the best way to decide on the LLOQ depending on pharmacokinetics point of view, rather than depending on the analytical parameters to decide?


That’s the only way to do it (we had this already)!

❝ Is there a proper way to estimate the linearity range from PK data rather than analytical approach?


Analytics is just a tool serving PK. You must cover the entire range from the highest Cmax observed in any of the subjects to a suitable LLOQ (covering 80% of AUC in the subject with the lowest levels).
The upper range is not so critical, because you may dilute samples above the ULOQ and re-analyse them. Of course the dilution step must be validated. ;-)
In BE linearity generally is not that critical, but in PK (e.g., multi-phasic models after an i.v. administration) sometimes it may be rather tough due to limited detector linearity in MS and fluorescence.

❝ My point can we work on the analytical method development depending on the PK and statistical output to design our analytical method? :-|


Sure, the PK-people should tell you what concentrations they expect in the study.
They may refer to previous studies, literature, or PK-simulations…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
74 visitors (0 registered, 74 guests [including 7 identified bots]).
Forum time: 11:27 CEST (Europe/Vienna)

It’s always fun to have your models validated,
but is way more fun to have them trashed.
Finding out you are completely wrong
is a great part of science.    G. Randall Gladstone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5